Skip to main content
TipRanks
Go Ultimate75% OFF

Su Zhen Insider Profile

4 Followers

Su Zhen, Director at CytomX Therapeutics, holds ― shares in CytomX Therapeutics (Ticker: CTMX), holds 15.51K shares in Karyopharm Therapeutics (Ticker: KPTIQ).

Su Zhen's Trading History

KPTIQ
Karyopharm Therapeutics
May 26, 2026DirectorUninformative Buy―$263.64
CTMX
CytomX Therapeutics
―Director――

You May Also Like

Su Zhen insider profile FAQ

What stocks does Su Zhen hold?
Su Zhen holds: CTMX, KPTIQ stocks.
What is Su Zhen's role in CytomX Therapeutics?
Su Zhen's role in CytomX Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.